Chao, C C, DeLaHunt, M, Hu, S et al. · Clinical immunology and immunopathology · 1992 · DOI
Researchers infected mice with agents that trigger immune system activation and found that the mice became fatigued—they ran much less on their exercise wheels and took longer to groom themselves after swimming. The infected mice also showed elevated levels of a immune signaling molecule called TGF-beta, which is also found at high levels in ME/CFS patients. This study suggests that an overly active immune response may be directly responsible for the fatigue experienced in ME/CFS.
This study provides experimental evidence that immune activation can directly cause fatigue symptoms, offering a mechanistic link between immune dysfunction and ME/CFS. The finding that TGF-β elevation parallels fatigue suggests a potential biomarker and therapeutic target for ME/CFS patients. A validated animal model for ME/CFS-like fatigue enables future studies of treatment strategies and underlying biological mechanisms.
This study does not prove that all human ME/CFS is immunologically mediated, nor does it establish that TGF-β is the sole cause of fatigue in patients. The presence of elevated TGF-β in both this model and CFS patients shows correlation, not necessarily causation in human disease. Results in inbred laboratory mice may not fully translate to the heterogeneous human population with ME/CFS.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.